The Advantages and Applications of Traditional Chinese Medicine in the Treatment of Liver Cancer

Authors

  • Yushan Ge

DOI:

https://doi.org/10.54097/cjg1vx03

Keywords:

Traditional Chinese medicine, Liver cancer, Huangqi.

Abstract

As one of the most common malignant tumors worldwide, liver cancer progresses rapidly and has a poor prognosis. Traditional Chinese medicine (TCM), due to its overall regulation and low toxicity, has gradually gained attention in the field of liver cancer treatment. The current research on TCM treatment for liver cancer has gradually deepened from clinical experience summary to mechanism exploration. This article systematically analyzes the clinical application and basic research literature of TCM treatment for liver cancer in recent years, and sorts out the effects of commonly used Chinese medicines (such as Huangqi and ginseng) and classic formulas (such as Lingmao formula) in inhibiting liver cancer cell proliferation, regulating tumor microenvironment, reducing the toxic side effects of radiotherapy and chemotherapy, promoting liver regeneration, etc. At the same time, it summarizes the clinical effects of modern medical methods such as TCM combined with surgery and interventional therapy in improving treatment efficiency, reducing recurrence rate, and improving patients' quality of life. However, the current evaluation system for the efficacy of TCM in treating liver cancer is not completely unified, and there is still a lack of long-term follow-up studies with multiple centers and large samples. Future research can further improve the efficacy evaluation criteria, strengthen the exploration of the synergistic mechanism of integrated traditional Chinese and Western medicine treatment, and carry out more high-quality clinical studies to verify the long-term efficacy of TCM.

Downloads

Download data is not yet available.

References

[1] Shu Y, He D, Li W, et al. Hepatoprotective Effect of Citrus aurantium L. Against APAP-induced Liver Injury by Regulating Liver Lipid Metabolism and Apoptosis. International Journal of Biological Sciences, 2020, 16 (5): 752 - 765.

[2] Chan S L, The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. The Lancet, 2025, 406 (10504): 731 - 778.

[3] Chen B W, Sun X H, Zhu X J, et al. A retrospective cohort study on traditional Chinese medicine treatment for preventing hepatocellular carcinoma in patients with compensated hepatitis B cirrhosis. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, 2025, 35 (3): 269 - 273.

[4] Xiao Y. Traditional Chinese Medicine Health Preservation: Nourishing the Liver in Spring Does Not Necessarily Mean Eating More Liver. Agricultural Products Market Weekly, 2014 (15): 55.

[5] Chen B, Huang W, Zhu P, et al. Clinical efficacy of Lingmao Formula combined with Tenofovir and Peginterferon α-2b in the treatment of chronic hepatitis B. Clinical Rational Drug Use, 2025, 18 (11): 86 - 88, 92.

[6] Li Y, Yang X, Bao T, et al. Radix Astragali decoction improves liver regeneration by upregulating hepatic expression of aquaporin-9. Phytomedicine, 2024, 122: 155166.

[7] Haroun R, Wood J N, Sikandar S. Mechanisms of cancer pain. Frontiers in Pain Research, 2022, 3: 1030899.

[8] Xu P, Xu W, Yuan W H, et al. Observation on the efficacy of thunder-fire moxibustion combined with opioids in the treatment of cancer pain. Laboratory Medicine and Clinic, 2021, 18 (19): 2875 - 2877.

[9] Wan Q, Yang Z Y, Guo C X, et al. Clinical efficacy of Shugan Jianpi Jiedu Formula in the treatment of liver depression and spleen deficiency syndrome after intrahepatic cholangiocarcinoma surgery. Academic Journal of Second Military Medical University, 2021 (1).

[10] Wan Z X. Effects of Shenqi Huayu Formula on liver fibrosis after TACE surgery for primary liver cancer and network pharmacology exploration [D]. Guangdong: Guangzhou University of Chinese Medicine, 2024.

[11] Chen D C, Yang X Y, Li H J, et al. Therapeutic study of rhubarb on gastrointestinal complications in critically ill patients. Chinese Journal of Emergency Medicine, 2001 (3).

[12] Han X, Wei Q, Lv Y, et al. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Molecular Therapy, 2022, 30 (1): 327 - 340.

Downloads

Published

28-12-2025

Issue

Section

Articles

How to Cite

Ge, Y. (2025). The Advantages and Applications of Traditional Chinese Medicine in the Treatment of Liver Cancer. Academic Journal of Science and Technology, 18(1), 325-329. https://doi.org/10.54097/cjg1vx03